-
Why Do Some People Who Have Never Smoked Get Lung Cancer?
As tobacco use has declined in recent years, we have seen a new demographic of lung cancer patients emerge. Lung cancer in individuals who have never smoked (LCINS) is becoming more common. These...
IN THE SPOTLIGHT
-
2025 ASCO: Highlights of Lung Cancer Research
The annual meeting of the American Society of Clinical Oncology (ASCO) once again brought together nearly 50,000 members of the oncology community. From May 30 – June 2... -
Leptomeningeal Spread in Lung Cancer
As patients with lung cancer are living longer, some are developing leptomeningeal disease (LMD) beyond brain metastases. There are few options for treating this type of central... -
Surviving LMD: Michelle Never Settled for “No”
Michelle knew what was wrong. She knew the headaches, regular vomiting, ear popping, and “whooshing” sounds in her head were all signs of leptomeningeal disease (LMD). The issue... -
Panelists Discuss New Advances from ASCO 2025
The publication OncLive convened a panel of experts to break down the SCLC news from the ASCO conference held in June 2025. Panelists discussed strategies for treating limited... -
Mark your Calendar! Small Cell SMASHERS Fireside Chat
Join us for a Facebook Live on Friday, August 22, to learn about integrative medicine with Kim Lowery Walker, MBA, LCSW, Integrative Psycho-Oncology Program Manager and oncology... -
Small Cell SMASHERS Fireside Chat: Drs. Gieske and Hanna
In this Facebook Live from June 20, special guests Michael Gieske, MD, St. Elizabeth Cancer Center, and Nasser Hanna, MD, Indiana University School of Medicine, presented "Lung... -
Hot Topic Highlights: 2025 Small Cell Lung Cancer Meeting
Read time: 6 minutes. April turned out to be an exciting month for lung cancer science. First, we attended the 2025 Small Cell Lung Cancer (SCLC) Hot Topic Meeting held in New York... -
SCLC Virtual Meetup
SCLC patients/survivors - Join us the 3rd Wednesday of every month to c onnect with others who share common experiences and build your community. Register in advance for this...
Anlotinib/Irinotecan Shows Promise, Durable Responses in ES-SCLC
Immunotherapy and T-Cell–Directed Therapy Expand Treatment Approaches in Small Cell Lung Cancer
Immunotherapy and T-Cell–Directed Therapy Expand Treatment Approaches in Small Cell Lung Cancer
Daiichi Sankyo Presents New Data in Small Cell Lung Cancer and Updates Across ADC Portfolio Highlighting Progress in Creating New Standards of Care for Patients with Lung Cancer at WCLC
Daiichi Sankyo Presents New Data in Small Cell Lung Cancer and Updates Across ADC Portfolio Highlighting Progress in Creating New Standards of Care for Patients with Lung Cancer at WCLC
Potential New Second-Line Standard of Care Emerges in Small Cell Lung Cancer
Aarhus University Hospital Researchers Update Current Data on Brain Metastasis (Role of prophylactic cranial irradiation in patients with limited disease small cell lung cancer: A...
Aarhus University Hospital Researchers Update Current Data on Brain Metastasis (Role of prophylactic cranial irradiation in patients with limited disease small cell lung cancer: A...
Gene inhibitor found to boost immunotherapy for most aggressive form of lung cancer
MET Gene Inhibitor Found to Enhance Chemotherapy and Immunotherapy Effectiveness in Small Cell Lung Cancer Study
MET Gene Inhibitor Found to Enhance Chemotherapy and Immunotherapy Effectiveness in Small Cell Lung Cancer Study
Gene inhibitor found to boost immunotherapy for most aggressive form of lung cancer
Adding MET inhibitor enhances immune response against small cell lung tumors
Real-World Response and Survival Outcomes and Treatment Patterns in Patients With Extensive Stage Small-Cell Lung Cancer Receiving Third-Line Treatment
Real-World Response and Survival Outcomes and Treatment Patterns in Patients With Extensive Stage Small-Cell Lung Cancer Receiving Third-Line Treatment
Leptomeningeal Spread in Lung Cancer
Leptomeningeal Spread in Lung Cancer
As patients with lung cancer are living longer, some are developing leptomeningeal disease (LMD) beyond brain metastases. There are few options for treating this type of central nervous system metastases. Our community is looking for solutions, and the Leptomeningeal Cancer Foundation is doing extremely important work in this area.You are invited to join them for their upcoming webinar on LMD in lung cancer on Thursday, August 21, 2 pm ET. Register here: https://zoom.us/webinar/register/…
Why Do Some People Who Have Never Smoked Get Lung Cancer?
Why Do Some People Who Have Never Smoked Get Lung Cancer?
As tobacco use has declined in recent years, we have seen a new demographic of lung cancer patients emerge. Lung cancer in individuals who have never smoked (LCINS) is becoming more common. These people are often younger women with no history of tobacco exposure.Researchers are working to understand the needs of this growing population by identifying other risk factors for lung cancer, such as family history and environmental exposures. They are also studying the molecular underpinnings of this…
Panelists Discuss New Advances from ASCO 2025
Panelists Discuss New Advances from ASCO 2025
The publication OncLive convened a panel of experts to break down the SCLC news from the ASCO conference held in June 2025. Panelists discussed strategies for treating limited-stage (LS-SCLC) and extensive-stage (ES-SCLC) small cell lung cancer, including:Integration of durvalumab in LS-SCLCNew first-line chemoimmunotherapy regimens in ES-SCLCMaintenance approaches such as atezolizumab plus lurbinectedin and durvalumab plus tarlatamab (DeLLphi-305)The promising future role of agents including T…
2025 ASCO: Highlights of Lung Cancer Research
2025 ASCO: Highlights of Lung Cancer Research
The annual meeting of the American Society of Clinical Oncology (ASCO) once again brought together nearly 50,000 members of the oncology community. From May 30 – June 2, researchers, oncologists, and patient advocates had first-hand access to the latest cancer research news. The theme for the 2025 ASCO conference was “Driving Knowledge to Action: Building a Better Future.” This theme was represented through several presentations during the conference that showcased how the cancer…
Small Cell SMASHERS Fireside Chat: Drs. Gieske and Hanna
Small Cell SMASHERS Fireside Chat: Drs. Gieske and Hanna
In this Facebook Live from June 20, special guests Michael Gieske, MD, St. Elizabeth Cancer Center, and Nasser Hanna, MD, Indiana University School of Medicine, presented "Lung Cancer Screening: Eligibility, Engaging Healthcare Systems, and Impact for Lung Cancer including SCLC."Moderated by Misty Shields, MD, PhD, IU Health, and LUNGevity’s Ann Fish-Steagall, SVP of Patient Services and Health Care Delivery, the monthly Small Cell SMASHERS series highlights the latest discoveries and…
Surviving LMD: Michelle Never Settled for “No”
Surviving LMD: Michelle Never Settled for “No”
Michelle knew what was wrong. She knew the headaches, regular vomiting, ear popping, and “whooshing” sounds in her head were all signs of leptomeningeal disease (LMD). The issue, however, is that LMD is so rare—only diagnosed in 5% of people with cancer—she had to advocate for the testing to prove it.“I called my clinic and said I needed a brain MRI because I think I have LMD. They didn’t want to schedule one, so I said, tell my doctor I’m demanding a brain MRI. I can tell him directly if I…
Small Cell SMASHERS Fireside Chat: Dr. Nagla Karim
Small Cell SMASHERS Fireside Chat: Dr. Nagla Karim
On May 23, special guest Nagla Karim, MD, from the Inova Schar Cancer Institute, spoke with us about the application of subtyping and biomarkers for SCLC.Moderated by Misty Shields, MD, PhD, IU Health, and LUNGevity’s Ann Fish-Steagall, SVP of Patient Services and Health Care Delivery, the monthly Small Cell SMASHERS series highlights the latest discoveries and breakthroughs for SCLC.
Watch HOPE Summit Videos
Watch HOPE Summit Videos
HOPE Summit 2025 was filled with messages of hope, meeting new and hugging old friends, and of course the inspirational and informative sessions that help people live well with lung cancer. For the first time ever, select sessions were recorded for those who weren’t able to attend, and for those who did attend to rewatch what resonated. View the entire collection here or see below for the sessions you want to watch.HOPE Summit 2025 Recorded SessionsKeynote: Breathing Beyond Boundaries…
Watch HOPE Summit Videos
Watch HOPE Summit Videos
HOPE Summit 2025 was filled with messages of hope, meeting new and hugging old friends, and of course the inspirational and informative sessions that help people live well with lung cancer. For the first time ever, select sessions were recorded for those who weren’t able to attend, and for those who did attend to rewatch what resonated. View the entire collection here or see below for the sessions you want to watch.HOPE Summit 2025 Recorded SessionsKeynote: Breathing Beyond Boundaries…
Hot Topic Highlights: 2025 Small Cell Lung Cancer Meeting
Hot Topic Highlights: 2025 Small Cell Lung Cancer Meeting
Read time: 6 minutes. April turned out to be an exciting month for lung cancer science. First, we attended the 2025 Small Cell Lung Cancer (SCLC) Hot Topic Meeting held in New York from April 2-4, then the American Association for Cancer Research (AACR) Annual Meeting in Chicago from April 24-30.The SCLC Hot Topic Meeting, hosted by the International Association for the Study of Lung Cancer, has become one of our favorite science meetings. Held at the Memorial Sloan Kettering…
Small Cell SMASHERS Fireside Chat: Dr. Carl Gay
Small Cell SMASHERS Fireside Chat: Dr. Carl Gay
On April 25, special guest Carl Gay, MD, PhD, MD Anderson Cancer Center, joined us to discuss the role of subtyping and translational research in small cell lung cancer (SCLC).Moderated by Misty Shields, MD, PhD, IU Health, and LUNGevity’s Ann Fish-Steagall, SVP of Patient Services and Health Care Delivery, the monthly Small Cell SMASHERS series highlights the latest discoveries and breakthroughs for SCLC.
Integrative Oncology and Lung Cancer: Adding Complementary Therapy
Integrative Oncology and Lung Cancer: Adding Complementary Therapy
What Is Integrative Oncology? Integrative oncology is the use of complementary therapies alongside conventional lung cancer treatments like chemotherapy, targeted therapy, surgery, or immunotherapy. Integrative oncology—also called integrative medicine—is an evidence-informed whole-body approach to health. It is often used to address symptoms and side effects caused by disease or treatment and improve overall quality of life. Specific examples of integrative oncology for lung cancer…
Conversations that Count: Transforming Lung Cancer Care Through Insight and Innovation
Conversations that Count: Transforming Lung Cancer Care Through Insight and Innovation
The LUNGevity Conversations that Count speaker series offers an opportunity to stay informed, engage in critical discussions, and learn from top experts revolutionizing lung cancer care for underserved populations. The series is intended for healthcare professionals, community health equity champions, and anyone interested in equitable access to healthcare. In February, we welcomed Randi Williams, PhD, MPH, of the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center…
Small Cell SMASHERS Fireside Chat: Dr. Christopher Kniese
Small Cell SMASHERS Fireside Chat: Dr. Christopher Kniese
On Friday, March 14, Christopher Kniese, MD, of IU Health, discussed the role of pulmonologists in SCLC, why the right diagnosis is key, logistics and importance of a bronchoscopy/biopsy, pulmonary rehab, and other topics.Moderated by Misty Shields, MD, IU Health, and LUNGevity’s Ann Fish-Steagall, SVP of Patient Services and Health Care Delivery, this monthly virtual series highlights the latest discoveries and breakthroughs in SCLC.
Small Cell SMASHERS Fireside Chat: Drs. Baine and Rekhtman
Small Cell SMASHERS Fireside Chat: Drs. Baine and Rekhtman
On Friday, February 28, Drs. and Rekhtman of Memorial Sloan Kettering Cancer Center joined us on Facebook Live to discuss the role of pathologists in SCLC, why the right diagnosis is key, and the logistics and importance of biopsies. They explained forms of SCLC such as atypical, transformed, and RB proficient.Moderated by Misty Shields, MD, PhD, IU Health, and LUNGevity’s Ann Fish-Steagall, SVP of Patient Services and Health Care Delivery, this monthly virtual series highlights the latest…
Laughs for Lungs: Rasheed Marshall Combines Comedy With Cancer
Laughs for Lungs: Rasheed Marshall Combines Comedy With Cancer
Rasheed Marshall understands the secondhand effects of cancer well. First his mom, Joycelyn, was diagnosed with breast cancer in 1995. It came back in 2015 and eventually metastasized (spread) to her lungs. Soon after, his brother-in-law Romain was diagnosed with brain cancer. They both passed away the same week. “It was tough for the entire family when we learned mom’s cancer came back. She didn’t want to go through treatment again—which is why she didn’t tell us about it right away—so…
Staying Safe From Smoke, Pollution, and Dangerous Air Quality
Staying Safe From Smoke, Pollution, and Dangerous Air Quality
On the West Coast, wildfires are taking human lives and destroying homes. On the East Coast, the devastating results of Hurricane Helene are leading to illegal open burning of debris and trash. Thousands of miles separate these fires, but the results are the same—dangerous particles are entering the air we breathe. LUNGevity spoke with Angela Hopper, an 11-year lung cancer survivor who spent 30 years working as an air quality specialist at the North Carolina Department of Environmental…
Small Cell SMASHERS Fireside Chat: Dr. Mya Tran
Small Cell SMASHERS Fireside Chat: Dr. Mya Tran
Mya Tran, PharmD, BCOP, joined us in January to discuss what people should expect during treatment for small cell lung cancer (SCLC), managing side effects related to SCLC therapy, as well as the importance of genomics and its role in molecularly informed clinical trials for SCLC. Moderated by Dr. Misty Shields, IU Health, and LUNGevity’s Ann Fish-Steagall, SVP of Patient Services and Health Care Delivery, this monthly virtual series highlights the latest discoveries and breakthroughs in SCLC.…
Have You Heard About Cancer Cachexia?
Have You Heard About Cancer Cachexia?
Cachexia is a complex condition that causes severe muscle and weight loss, physical inactivity, and metabolic disruptions such as fatigue, nausea, and loss of concentration. It's estimated that 50% of individuals with lung cancer experience cachexia at some point.Learn more about cachexia and how to recognize the symptoms.
Conversations that Count: Understanding the Complexities of Race and Health
Conversations that Count: Understanding the Complexities of Race and Health
The LUNGevity Conversations that Count speaker series offers an opportunity to stay informed, engage in critical discussions, and learn from top experts revolutionizing lung cancer care for underserved populations. The series is intended for healthcare professionals, community health equity champions, and anyone interested in equitable access to healthcare. In January, we welcomed Matthew McCurdy, MPH, co-founder and executive director of BLKHLTH, to speak on the complexities of race and…